Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico

Sada, M; Saraya, T; Ishii, H; Okayama, K; Hayashi, Y; Tsugawa, T; Nishina, A; Murakami, K; Kuroda, M; Ryo, A; Kimura, H

MICROORGANISMS, 2020; 8 (10):

Abstract

Favipiravir was initially developed as an antiviral drug against influenza and is currently used in clinical trials against severe acute respiratory s......

Full Text Link